Literature DB >> 26779649

Retraction note to: KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer.

.   

Abstract

Entities:  

Year:  2015        PMID: 26779649     DOI: 10.1007/s10735-016-9653-8

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


× No keyword cloud information.
  26 in total

1.  Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma.

Authors:  Johan Linderoth; Mats Ehinger; Måns Akerman; Eva Cavallin-Ståhl; Gunilla Enblad; Martin Erlanson; Mats Jerkeman
Journal:  Eur J Haematol       Date:  2007-08       Impact factor: 2.997

2.  Role of the hypoxia-related gene, JMJD1A, in hepatocellular carcinoma: clinical impact on recurrence after hepatic resection.

Authors:  Daisaku Yamada; Shogo Kobayashi; Hirofumi Yamamoto; Yoshito Tomimaru; Takehiro Noda; Mamoru Uemura; Hiroshi Wada; Shigeru Marubashi; Hidetoshi Eguchi; Masahiro Tanemura; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  Ann Surg Oncol       Date:  2011-05-24       Impact factor: 5.344

3.  Reproducibility crisis: Blame it on the antibodies.

Authors:  Monya Baker
Journal:  Nature       Date:  2015-05-21       Impact factor: 49.962

4.  Epithelial ovarian cancer: An overview.

Authors:  Arpita Desai; Jingyao Xu; Kartik Aysola; Yunlong Qin; Chika Okoli; Ravipati Hariprasad; Ugorji Chinemerem; Candace Gates; Avinash Reddy; Omar Danner; Geary Franklin; Anachebe Ngozi; Guilherme Cantuaria; Karan Singh; William Grizzle; Charles Landen; Edward E Partridge; Valerie Montgomery Rice; E Shyam P Reddy; Veena N Rao
Journal:  World J Transl Med       Date:  2014-04-12

5.  The JmjC domain-containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 gene.

Authors:  Hyun-Soo Cho; Gouji Toyokawa; Yataro Daigo; Shinya Hayami; Ken Masuda; Noriko Ikawa; Yuka Yamane; Kazuhiro Maejima; Tatsuhiko Tsunoda; Helen I Field; John D Kelly; David E Neal; Bruce A J Ponder; Yoshihiko Maehara; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Int J Cancer       Date:  2011-12-21       Impact factor: 7.396

6.  The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.

Authors:  Lifei Jiang; Rong Liu; Yingying Wang; Chunmiao Li; Qinghua Xi; Jianxin Zhong; Jian Liu; Shuyun Yang; Juan Wang; Menghui Huang; Chunhui Tang; Zheng Fang
Journal:  J Mol Histol       Date:  2015-05-17       Impact factor: 2.611

7.  The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables.

Authors:  Gulay Turan; Ceyda Sancakli Usta; Akin Usta; Mehmet Kanter; Lema Tavli; Meric Karacan; Cetin Celik; Metin Eser
Journal:  J Mol Histol       Date:  2014-08-09       Impact factor: 2.611

Review 8.  Management of recurrent epithelial ovarian cancer.

Authors:  Víctor Manuel Vargas-Hernández; Mario Adan Moreno-Eutimio; Gustavo Acosta-Altamirano; Víctor Manuel Vargas-Aguilar
Journal:  Gland Surg       Date:  2014-08

Review 9.  Histone demethylase JHDM2A is involved in male infertility and obesity.

Authors:  Yuki Okada; Keisuke Tateishi; Yi Zhang
Journal:  J Androl       Date:  2009-10-29

10.  The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer.

Authors:  Mark A Wade; Dominic Jones; Laura Wilson; Jacqueline Stockley; Kelly Coffey; Craig N Robson; Luke Gaughan
Journal:  Nucleic Acids Res       Date:  2014-12-08       Impact factor: 16.971

View more
  2 in total

1.  Expression of AQP6 and AQP8 in epithelial ovarian tumor.

Authors:  Jiong Ma; Chunxia Zhou; Jianhua Yang; Xiaoyan Ding; Yunshan Zhu; Xuejun Chen
Journal:  J Mol Histol       Date:  2016-01-16       Impact factor: 2.611

2.  Aberrant CDK9 expression within chordoma tissues and the therapeutic potential of a selective CDK9 inhibitor LDC000067.

Authors:  Shen Shen; Dylan C Dean; Zujiang Yu; Francis Hornicek; Quancheng Kan; Zhenfeng Duan
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.